Exercise Therapy for Femoroacetabular Impingement Syndrome (SWEaT)

December 18, 2023 updated by: Schulthess Klinik

The Effect of Patients' Characteristics on the Responsiveness to Exercise Therapy for the Management of Femoroacetabular Impingement Syndrome: a Multi-center, Single-group, Intervention Study

The aim of the clinical trial is to investigate the characteristics of patients, who respond vs. not respond to exercise therapy for the nonsurgical management of femoroacetabular impingement syndrome (FAIS).

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Patients with a diagnosis of FAIS will be recruited from 2 clinical centers and will receive exercise therapy (study intervention). Exercise therapy is a semi-standardized intervention and will last 12 weeks (3 months). Hip pain, function and quality of life will be assessed using a patient-reported questionnaire at baseline, 3, 6 and 12 months' follow-up. Hip joint contact pressure will be evaluated using motion analysis and modelling at baseline, 3 and 12 months' follow-up. Hip morphology will be evaluated using imaging at baseline and hip surgery rate will be evaluated at 6 and 12 months' follow-up.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age: 18 to 50 years;
  • Diagnosis of FAIS;
  • Availability of magnetic resonance arthrography and anteroposterior pelvic radiography of the involved hip;
  • Signed informed consent form.

Exclusion Criteria:

  • Previous hip surgery;
  • Any surgery on the lower extremities in the last 6 months;
  • Hip dysplasia: lateral center edge angle <25°;
  • Hip osteoarthritis: Tönnis grade >1;
  • BMI: >35 kg/m2;
  • Significant cardiopulmonary diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise therapy
Exercise therapy consists of improving dynamic hip joint stability by means of hip-specific and functional lower limb strengthening, core stability and postural balance exercises.
  • Education
  • Hip-specific strengthening exercises
  • Functional lower limb strengthening exercises
  • Core stability exercises
  • Postural balance exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in hip pain, function and quality of life
Time Frame: Baseline to 6 months' follow-up
Hip pain, function and quality of life will be assessed using the International Hip Outcome Tool - 33 Items
Baseline to 6 months' follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in hip pain, function and quality of life
Time Frame: Baseline to 12 months' follow-up
Hip pain, function and quality of life will be assessed using the International Hip Outcome Tool - 33 Items
Baseline to 12 months' follow-up
Change in hip pain, function and quality of life
Time Frame: Baseline to 3 months' follow-up
Hip pain, function and quality of life will be assessed using the International Hip Outcome Tool - 33 Items
Baseline to 3 months' follow-up
Change in hip joint contact stress
Time Frame: Baseline to 3 months' follow-up
Hip joint contact pressure will be assessed using modelling
Baseline to 3 months' follow-up
Change in hip joint contact stress
Time Frame: Baseline to 12 months' follow-up
Hip joint contact pressure will be assessed using modelling
Baseline to 12 months' follow-up
Hip morphology
Time Frame: Baseline
Hip morphology will be assessed using imaging
Baseline
Change in sport activity level
Time Frame: Baseline to 3 months' follow-up
Sport activity level will be assessed using the Hip Sports Activity Scale
Baseline to 3 months' follow-up
Change in sport activity level
Time Frame: Baseline to 6 months' follow-up
Sport activity level will be assessed using the Hip Sports Activity Scale
Baseline to 6 months' follow-up
Change in sport activity level
Time Frame: Baseline to 12 months' follow-up
Sport activity level will be assessed using the Hip Sports Activity Scale
Baseline to 12 months' follow-up
Hip surgery rate
Time Frame: 6 months' follow-up
Number of patients who will decide to undergo hip surgery
6 months' follow-up
Hip surgery rate
Time Frame: 12 months' follow-up
Number of patients who will decide to undergo hip surgery
12 months' follow-up
Dropout
Time Frame: 3 months' follow-up
Number of patients who will not complete the non-surgical intervention protocol
3 months' follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nicola C Casartelli, PhD, Schulthess Klinik

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2019

Primary Completion (Estimated)

March 1, 2024

Study Completion (Estimated)

March 1, 2024

Study Registration Dates

First Submitted

June 14, 2019

First Submitted That Met QC Criteria

August 3, 2020

First Posted (Actual)

August 6, 2020

Study Record Updates

Last Update Posted (Estimated)

December 19, 2023

Last Update Submitted That Met QC Criteria

December 18, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Femoroacetabular Impingement Syndrome

Clinical Trials on Exercise therapy

Subscribe